References

Adams R. Improving health outcomes with better patient understanding and education. Risk Management and Healthcare Policy. 2010; https://doi.org/10.2147/rmhp.s7500

Chakrabarty S, Zoorob R. Fibromyalgia. Am Fam Physician. 2007; 76:(2)247-54

Choy E, Perrot S, Leon T A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Services Research. 2010; 10:(1) https://doi.org/10.1186/1472-6963-10-102

Dedhia JD, Bone ME. Pain and fibromyalgia. Continuing Education in Anaesthesia Critical Care & Pain. 2009; 9:(5)162-166 https://doi.org/10.1093/bjaceaccp/mkp026

Derry S, Cording M, Wiffen PJ, Law S, Phillips T, Moore RA. Pregabalin for pain in fibromyalgia in adults. Cochrane Database of Systematic Reviews. 2016; https://doi.org/10.1002/14651858.cd011790.pub2

Derry S, Rice AS, Cole P, Tan T, Moore RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews. 2017; https://doi.org/10.1002/14651858.cd007393.pub4

Duehmke RM, Derry S, Wiffen PJ, Bell RF, Aldington D, Moore RA. Tramadol for neuropathic pain in adults. Cochrane Database of Systematic Reviews. 2017; https://doi.org/10.1002/14651858.cd003726.pub4

Hassett AL, Gevirtz RN. Nonpharmacologic Treatment for Fibromyalgia: Patient Education, Cognitive-Behavioral Therapy, Relaxation Techniques, and Complementary and Alternative Medicine. Rheumatic Disease Clinics of North America. 2009; 35:(2)393-407 https://doi.org/10.1016/j.rdc.2009.05.003

Häuser W, Walitt B, Fitzcharles M-A, Sommer C. Review of pharmacological therapies in fibromyalgia syndrome. Arthritis Research & Therapy. 2014; 16:(1) https://doi.org/10.1186/ar4441

Hawkins R. Fibromyalgia: A Clinical Update. The Journal of the American Osteopathic Association. 2013; 113:(9)680-689 https://doi.org/10.7556/jaoa.2013.034

Hughes G, Martinez C, Myon E, Taïeb C, Wessely S. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: An observational study based on clinical practice. Arthritis & Rheumatism. 2005; 54:(1)177-183 https://doi.org/10.1002/art.21545

Jahan F, Nanji K, Qidwai W, Qasim R. Fibromyalgia Syndrome: An Overview of Pathophysiology, Diagnosis and Management. Oman Medical Journal. 2012; 27:(3)192-195 https://doi.org/10.5001/omj.2012.44

British National Formulary (BNF).London: Pharmaceutical Press; 2014

Kodner C. Common Questions About the Diagnosis and Management of Fibromyalgia. 2015; 91:(7)472-8

Chronic widespread pain, including fibromyalgia: a pathway for care developed by the British Pain Society. https://academic.oup.com/bja/article/112/1/16/243246 (accessed 21/3/2020)

Macfarlane GJ, Kronisch C, Dean LE EULAR revised recommendations for the management of fibromyalgia. Annals of the Rheumatic Diseases. 2016; 76:(2)318-328 https://doi.org/10.1136/annrheumdis-2016-209724

Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for fibromyalgia in adults. Cochrane Database of Systematic Reviews. 2015; https://doi.org/10.1002/14651858.cd011824

Northcott MJ, Guymer EK, Littlejohn GO. Pharmacological treatment options for fibromyalgia. Clinical Pharmacist. 2017; https://doi.org/10.1211/cp.2017.20203533

NRS Healthcare. Fibromyalgia. 2019. https://www.nrshealthcare.co.uk/articles/condition/fibromyalgia (accessed 18 January 2020)

Tidy. Fibromyalgia. 2014. https://patient.info/doctor/fibromyalgia-pro (accessed 18 Janaury 2020)

Walitt B, Urrútia G, Nishishinya MB, Cantrell SE, Häuser W. Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Sao Paulo Medical Journal. 2015; 133:(5)454-454 https://doi.org/10.1590/1516-3180.20151335t1

Welsch P, Üçeyler N, Klose P, Walitt B, Häuser W. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. Cochrane Database of Systematic Reviews. 2018; https://doi.org/10.1002/14651858.cd010292.pub2

Wiffen PJ, Derry S, Moore RA Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews. The Cochrane database of systematic reviews. 2013; 2013:(11) https://doi.org/10.1002/14651858.CD010567.pub2

Wiffen PJ, Derry S, Lunn MPT Topiramate for treating neuropathic pain or fibromyalgia. Cochrane Database of Systematic Reviews. 2015; 5:1465-1858 https://doi.org/10.1002/14651858.CD008314.pub2

Treatment and management of fibromyalgia

02 April 2020
Volume 2 · Issue 4

Abstract

This article will give and overview of this fibromyalgia, a highly complex disease, which presents in many cases with a variety of symptoms, making diagnosis extremely difficult. There are a number of treatment options available both non-pharmacological and pharmacological, and although the former are usually tried first, this article will largely focus on the later. The article aims to give non-medical prescribers more knowledge and confidence when faced with prescribing for this highly complicated disease.

Fibromyalgia is a poorly understood condition, estimated to affect approximately 1.5-2 million people in the UK. (NRS Healthcare, 2019). The disease can affect any age, but is most commonly seen in those aged between 30-50 years old. Women are much more likely to develop the condition than men (Tidy, 2014). The illness places a huge burden on healthcare resources with high levels of prescribing, testing, referrals and visit rates in the three years leading up to the diagnosis (Hughes et al, 2005). The high number of referrals or diagnostic investigations may have been caused by clinicians struggling to find a cause for the patients worsening symptoms and frequent appointments. It is thought likely that the true prevalence rates may be much higher than statistics suggest because some sufferers with milder symptoms may self-medicate with over the counter preparations and never seek help, or because of the complex nature of the disease and its variable presentation, may be misdiagnosed. It is hoped that this article will give nurses and non-medical prescribers an overview of this illness and help them when advising and treating their patients.

Register now to continue reading

Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month